<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cleanroom-Facilities on Bioecon</title><link>https://en.bioecon.ru/clusters/cleanroom-facilities/</link><description>Recent content in Cleanroom-Facilities on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 26 Jul 2026 21:59:35 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/clusters/cleanroom-facilities/index.xml" rel="self" type="application/rss+xml"/><item><title>Bio-cosmetic production equipment</title><link>https://en.bioecon.ru/technology/bio-cosmetic-production-equipment/</link><pubDate>Sat, 25 Jul 2026 23:25:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bio-cosmetic-production-equipment/</guid><description>The high-shear rotor-stator mixers, multi-shaft dispersers and monobloc cosmetic filling and packaging lines that turn oil and water phases plus recombinant actives into stable, cleanroom-grade emulsions — the manufacturing hardware behind clean-beauty, cell-culture-derived and biotech skincare.</description></item><item><title>Media manufacturing (B2B production equipment)</title><link>https://en.bioecon.ru/technology/media-manufacturing-equipment/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/media-manufacturing-equipment/</guid><description>GMP equipment lines for B2B dry-powder and liquid cell-culture media — cryogenic pin milling, ribbon-blend homogenisation and 0.1 um sterile fill — supplying the chemically-defined, animal-component-free media demand of mAb and cell-therapy biomanufacturing.</description></item><item><title>Modular / mobile cleanrooms</title><link>https://en.bioecon.ru/technology/modular-mobile-cleanrooms/</link><pubDate>Wed, 24 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/modular-mobile-cleanrooms/</guid><description>Prefabricated, autonomous cleanroom infrastructures delivering rapid deployment, scalable capacity, and guaranteed cGMP compliance for the rapidly evolving biomanufacturing and cell therapy sectors.</description></item></channel></rss>